Vaccinex, Inc. Proceeds from Long-Term Debt Issued
Vaccinex, Inc. (VCNX) reported Proceeds from Long-Term Debt Issued of $1.13 million for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-31.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2022-03-31
- Vaccinex, Inc. proceeds from issuance of long-term debt for the quarter ending 2020-12-31 was $0.00.
- Vaccinex, Inc. proceeds from issuance of long-term debt for the quarter ending 2020-09-30 was $0.00.
- Vaccinex, Inc. proceeds from issuance of long-term debt for fiscal 2020 was $1.13M.
| Period end | Proceeds from Issuance of Long-term Debt 3 month | Proceeds from Issuance of Long-term Debt 6 month | Proceeds from Issuance of Long-term Debt 9 month | Proceeds from Issuance of Long-term Debt 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $0.00 derived: sum of 2 quarters · filed 2022-03-31 | $1.13M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $1.13M 10-Q · filed 2021-11-08 | ||
| 2020-06-30 | $1.13M 10-Q · filed 2021-08-16 |